Tim Power | Vice President, Investor Relations |
Giovanni Caforio | Board Chair & Chief Executive Officer |
David Elkins | Chief Financial Officer |
Chris Boerner | Chief Commercialization Officer |
Samit Hirawat | Chief Medical Officer & Head of Global Drug Development |
Andrew Baum | Citi |
Geoff Meacham | Bank of America |
Chris Schott | JPMorgan |
Steve Scala | Cowen |
Seamus Fernandez | Guggenheim |
Luisa Hector | Berenberg |
Tim Anderson | Wolfe Research |
Evan Seigerman | BMO |
Terence Flynn | Morgan Stanley |
Matthew Phipps | William Blair |
Carter Gould | Barclays |
Dane Leone | Raymond James |
Colin Bristow | UBS |
Mohit Bansal | Wells Fargo |
Robyn Karnauskas | Truist Securities |
Good day and welcome to the Bristol-Myers Squibb 2022 Second Quarter Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the call over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir.